LifeMD, Inc. (LFMD)
| Market Cap | 196.18M |
| Revenue (ttm) | 64.41M |
| Net Income (ttm) | -84.88M |
| Shares Out | 26.56M |
| EPS (ttm) | -4.06 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 159,012 |
| Open | 7.30 |
| Previous Close | 7.35 |
| Day's Range | 6.91 - 7.35 |
| 52-Week Range | 5.81 - 33.02 |
| Beta | 0.67 |
| Analysts | Strong Buy |
| Price Target | 30.00 (+331.7%) |
| Est. Earnings Date | Nov 15, 2021 |
About LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medic...
Financial Performance
In 2020, LifeMD's revenue was $37.29 million, an increase of 199.10% compared to the previous year's $12.47 million. Losses were -$58.65 million, 1,769.4% more than in 2019.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for LifeMD stock is "Strong Buy" and the 12-month stock price forecast is 30.00.
News
LifeMD to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescripti...
LifeMD Partners With Prescryptive Health, Expanding Convenience and Affordability for Patients
Strategic partnership provides LifeMD with a vertically integrated, best-in-class pharmacy fulfillment and e-prescribing technology platform and immediate access to nationwide pharmacy network Strategic...
New Strong Sell Stocks for August 26th
FSLY, GNSS, LFMD, NUAN, and QUOT have been added to the Zacks Rank #5 (Strong Sell) List on August 26, 2021
LifeMD, Inc. (LFMD) Reports Q2 Loss, Tops Revenue Estimates
LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of -13.33% and 3.45%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
LifeMD Reports Q2 2021 Revenue Up 145% to Record $22.3 Million, Driven by Reduced Acquisition Costs and Strong Retention
NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the second quarter ended June 30, 2021. All figure compariso...
Earnings Preview: LifeMD, Inc. (LFMD) Q2 Earnings Expected to Decline
LifeMD, Inc. (LFMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LifeMD to Release Second Quarter 2021 Financial Results on Thursday, August 12, 2021
Hosted conference call to begin at 4:30 p.m. ET Hosted conference call to begin at 4:30 p.m. ET
LifeMD Teams with a Leading Provider of Diagnostic Services and Axle Health to Deliver Telehealth Access to At-Home D...
Patients Gain Access to Comprehensive Suite of Laboratory and Diagnostic Services at Preferred Pricing, Performed in the Comfort and Convenience of Home Patients Gain Access to Comprehensive Suite of La...
7 Meme Stocks to Buy for Their ‘To-the-Moon' Potential
These seven meme stocks to buy could be good picks for July as investor interest in these high-risk, high-return plays continues to grow. The post 7 Meme Stocks to Buy for Their ‘To-the-Moon' Potential ...
LifeMD Names Experienced Pharma Executive Alexander Mironov as President
A seasoned industry veteran, Mr. Mironov has led transformational M&A and business development transactions in pharma and healthcare, totaling over $5 billion
LifeMD™ Completes $15M Debt Financing
Financing significantly bolsters liquidity position to support continued investment in growth of telehealth business Financing significantly bolsters liquidity position to support continued investment i...
LifeMD to Present at Upcoming June Investor Conferences
NEW YORK, May 28, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that management will present at the Capital Peak Advisors ...
Plaintiffs in Shareholder Suits Drop Claims Against LifeMD
Cases voluntarily dismissed; company remains focused on growth, increasing access to healthcare via telemedicine Cases voluntarily dismissed; company remains focused on growth, increasing access to heal...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in LifeMD, Inc. f/k/a Conv...
NEW YORK, May 25, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. f/k/a Conversion Labs, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) and ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in LifeMD, Inc. f/k/a Conv...
New York, New York--(Newsfile Corp. - May 22, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. f/k/a Conversion Labs, Inc. ("LifeMD" or the "Company") (NAS...
CORRECTING and REPLACING Robbins Geller Rudman & Dowd LLP Announces Lead Plaintiff Deadline in the LifeMD, Inc. Class...
SAN DIEGO--(BUSINESS WIRE)-- #LFMDstock--The suit alleges defendants issued false statements concerning LifeMD business and prospects, resulting in its stock trading at inflated prices.
Robbins Geller Rudman & Dowd LLP Announces Lead Plaintiff Deadline in the LifeMD, Inc. Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)-- #LFMDstock--The suit alleges defendants issued false statements concerning LifeMD business and prospects, resulting in its stock trading at inflated prices.
Star Actresses Kate del Castillo and Bellamy Young Partner With LifeMD as Brand Ambassadors For Shapiro MD
The partnerships introduce celebrity influencers and their successful results using Shapiro MD™ hair loss treatment solutions to a large and global following The partnerships introduce celebrity influen...
LifeMD™ Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, May 17, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that the Compensation Committee of the Company's B...
LifeMD Shares Shoot Higher On Robust Q1 Telemedicine Revenues, FY Revenue Outlook Exceeding Consensus
LifeMD Inc (NASDAQ: LFMD) reported Q1 adjusted EPS loss of $(0.38) better than the consensus loss of $(0.67). Revenue increased 323% Y/Y to a record $18.2 million in line with the consensus, primarily d...
LifeMD, Inc. (LFMD) Reports Q1 Loss, Lags Revenue Estimates
LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 13.64% and -0.12%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
LifeMD Reports Q1 2021 Revenue up 323% to Record $18.2M, Raises Full Year Revenue Guidance to $90-$100M
NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today reported results for the first quarter ended March 31, 2021....
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against LifeMD, Inc. (L...
LOS ANGELES, May 13, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 15, 2021 deadline to file a lead plaintiff motion in the class action filed on behal...
Do Options Traders Know Something About LifeMD (LFMD) Stock We Don't?
Investors need to pay close attention to LifeMD (LFMD) stock based on the movements in the options market lately.